Last updated: April 7, 2024
Sponsor: Pusan National University Yangsan Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Primary Biliary Cholangitis
Treatment
Placebo group
Panax Ginseng C.A. Mey Extract group
Clinical Study ID
NCT03775837
02-2018-031
Ages 19-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ALT ranging from upper limit of reference to three times of upper limit
Exclusion
Exclusion Criteria:
- Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times ofupper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
- Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
- History of viral hepatitis or cancer
- Uncontrolled hypertension
- History of serious cardiac disease such as angina or myocardial infarction
- History of gastrectomy
- History of medication for psychiatric disease
- Administration of oriental medicine including herbs within the past 4 weeks
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Placebo group
Phase:
Study Start date:
December 01, 2018
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Integrated Research Institute for Natural Ingredients and Functional Foods
Yangsan, 50612
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.